1)牛久哲男,深山正久.AFP産生胃癌.腫瘍病理鑑別診断アトラス─胃癌.文光堂,pp 116-123,2009
2)Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Cancer 58 : 119-126, 1986
3)Ishikura H, Fukasawa Y, Ogasawara K, et al. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer 56 : 840-848, 1985
4)Matsunou H, Konishi F, Jalal RE, et al. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer 73 : 534-540, 1994
5)Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 33 : 1065-1077, 2009
6)Cao D, Guo S, Allan RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 33 : 894-904, 2009
7)Zynger DL, Dimov ND, Luan C, et al. Glypican 3 : a novel marker in testicular germ cell tumors. Am J Surg Pathol 30 : 1570-1575, 2006
8)Ushiku T, Shinozaki A, Shibahara J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 34 : 533-540, 2010
9)Ushiku T, Uozaki H, Shinozaki A, et al. Glypican 3-expressing gastric carcinoma : distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci 100 : 626-632, 2009
10)Filmus J, Church JG, Buick RN. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 8 : 4243-4249, 1988
11)Gitlin D, Perricelli A, Gitlin GM. Synthesis of α-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 32 : 979-982, 1972
12)Tsubooka N, Ichisaka T, Okita K, et al. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells 14 : 683-694, 2009
13)Skotheim RI, Lind GE, Monni O, et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65 : 5588-5598, 2005
14)Kono K, Amemiya H, Sekikawa T, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19 : 359-65 ; discussion 365, 2002
15)Chang YC, Nagasue N, Abe S, et al. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87 : 321-325, 1992
16)Ghotli ZA, Serra S, Chetty R. Clear cell(glycogen rich)gastric adenocarcinoma : a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathology 39 : 466-469, 2007
17)Govender D, Ramdial PK, Clarke B, et al. Clear cell(glycogen-rich)gastric adenocarcinoma. Ann Diagn Pathol 8 : 69-73, 2004
18)Uefuji K, Ichikura T, Tamakuma S. Clinical and prognostic characteristics of papillary clear carcinoma of stomach. Surg Today 26 : 158-163, 1996
19)Nagai E, Ueyama T, Yao T, et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer 72 : 1827-1835, 1993
20)Kobayashi A, Hasebe T, Endo Y, et al. Primary gastric choriocarcinoma : two case reports and a pooled analysis of 53 cases. Gastric Cancer 8 : 178-185, 2005
21)Wang L, Tabbarah HJ, Gulati P, et al. Gastric adenocarcinoma with a yolk sac component : a case report and review of the literature. J Clin Gastroenterol 31 : 85-88, 2000
22)Eom BW, Jung SY, Yoon H, et al. Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma. World J Gastroenterol 15 : 5106-5108, 2009
23)Motoyama T, Aizawa K, Fujiwara T, et al. Coexistence of choriocarcinoma and hepatoid adenocarcinoma in the stomach. Pathol Int 44 : 716-721, 1994
24)Kusafuka K, Bando E, Muramatsu K, et al. Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach : a report of an extremely rare case. Med Mol Morphol 42 : 167-174, 2009